• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

是否是时候采取大麻危害减少措施了?对 Sherman 等人(2022 年)和 Borodovsky 等人(2022 年)的评论。

Is it time for a cannabis harm reduction approach? Commentary on Sherman et al. (2022) and Borodovsky et al. (2022).

机构信息

Medical University of South Carolina, Department of Psychiatry and Behavioral Sciences.

出版信息

Psychol Addict Behav. 2023 Aug;37(5):709-712. doi: 10.1037/adb0000927.

DOI:10.1037/adb0000927
PMID:37523304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10403263/
Abstract

OBJECTIVE

Recent research suggests potential therapeutic benefits of cannabis-derived products, a lower risk profile than other illicit substances, and significant functional improvement from reduced use. Likewise, low abstinence rates and low motivation to achieve abstinence among those with cannabis use disorder (CUD) are the norm. As such, the harm reduction model has gained traction among substance use scientists and health care professionals as a viable alternative approach. Yet, to date no formal definition of cannabis harm reduction has been proposed.

METHOD

We reviewed the literature, including two recent empirical papers published in the , Sherman et al. (2022) and Borodovsky et al. (2022), which demonstrate that harm reduction is sufficient to achieve functional improvement. We then propose and define a harm reduction approach for cannabis use research and treatment, and argue why this approach is a timely, necessary discussion.

RESULTS

We suggest that a cannabis harm reduction approach includes treatment, research, and education initiatives that reduce the public health burden of cannabis use. This approach includes interventions that reduce functional impairment and risk from cannabis, reduced or managed use, and sometimes, but not necessarily, abstinence. Psychoeducation for treatment providers, legislative barriers, and research recommendations are also discussed.

CONCLUSIONS

Research and treatment for CUD has historically focused on cannabis abstinence. Treatment trials rarely yield durable abstinence rates, and reduction has recently been tied to functional improvement. We comment on Sherman et al. (2022) and Borodovsky et al. (2022) and propose a shift toward a cannabis harm reduction approach. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

摘要

目的

最近的研究表明,大麻衍生产品具有潜在的治疗益处,其风险比其他非法物质低,且减少使用后功能显著改善。同样,大麻使用障碍(CUD)患者的戒断率低,戒断意愿低也是常态。因此,减少伤害模式在物质使用科学家和医疗保健专业人员中获得了关注,成为一种可行的替代方法。然而,迄今为止,尚未提出大麻减少伤害的正式定义。

方法

我们回顾了文献,包括最近发表在《柳叶刀-精神病学》上的两篇实证论文,Sherman 等人(2022 年)和 Borodovsky 等人(2022 年),这两篇论文表明减少伤害足以实现功能改善。然后,我们提出并定义了一种用于大麻使用研究和治疗的减少伤害方法,并论证了为什么这种方法是一个及时且必要的讨论。

结果

我们认为,大麻减少伤害方法包括减少大麻使用的公共卫生负担的治疗、研究和教育举措。该方法包括减少功能障碍和风险的干预措施、减少或管理使用,有时,但不一定是戒断。还讨论了针对治疗提供者的心理教育、立法障碍和研究建议。

结论

CUD 的研究和治疗历来侧重于大麻戒断。治疗试验很少产生持久的戒断率,最近的研究表明减少使用与功能改善有关。我们评论了 Sherman 等人(2022 年)和 Borodovsky 等人(2022 年)的研究,并提出转向大麻减少伤害方法。

相似文献

1
Is it time for a cannabis harm reduction approach? Commentary on Sherman et al. (2022) and Borodovsky et al. (2022).是否是时候采取大麻危害减少措施了?对 Sherman 等人(2022 年)和 Borodovsky 等人(2022 年)的评论。
Psychol Addict Behav. 2023 Aug;37(5):709-712. doi: 10.1037/adb0000927.
2
Goal commitment predicts cannabis use for adolescents in treatment.目标承诺可预测治疗中青少年的大麻使用情况。
Subst Abus. 2019;40(4):496-500. doi: 10.1080/08897077.2019.1573207. Epub 2019 Feb 27.
3
Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: Obstacles and opportunities for improvement.与污名相关的医用大麻作为物质使用障碍减少伤害的障碍:改进的障碍和机会。
Int J Ment Health Nurs. 2024 Feb;33(1):195-201. doi: 10.1111/inm.13231. Epub 2023 Sep 28.
4
Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth.应急管理与非治疗寻求青少年在停止奖励后态度的积极变化和大麻使用的减少有关。
Drug Alcohol Depend. 2024 Mar 1;256:111096. doi: 10.1016/j.drugalcdep.2024.111096. Epub 2024 Jan 20.
5
Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.改善物质使用障碍康复期学生行为和学业成果的康复学校:一项系统综述
Campbell Syst Rev. 2018 Oct 4;14(1):1-86. doi: 10.4073/csr.2018.9. eCollection 2018.
6
A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.一项旨在减少早期精神病患者大麻使用和复发时间的权变管理干预措施:CIRCLE RCT。
Health Technol Assess. 2019 Aug;23(45):1-108. doi: 10.3310/hta23450.
7
Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.评估大麻使用减少风险作为大麻使用障碍的替代临床结局。
Psychol Addict Behav. 2022 Aug;36(5):505-514. doi: 10.1037/adb0000760. Epub 2021 Jul 1.
8
Motivational Interviewing for Cannabis Use Disorders: A Systematic Review and Meta-Analysis.动机性访谈治疗大麻使用障碍:系统评价和荟萃分析。
Eur Addict Res. 2021;27(6):413-427. doi: 10.1159/000515667. Epub 2021 May 7.
9
Use of Cannabis for Harm Reduction Among People at High Risk for Overdose in Vancouver, Canada (2016-2018).加拿大温哥华高危药物过量人群的大麻危害减少使用情况(2016-2018 年)。
Am J Public Health. 2021 May;111(5):969-972. doi: 10.2105/AJPH.2021.306168. Epub 2021 Mar 18.
10
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale.有精神病的年轻人对以大麻为重点的减少伤害干预的偏好:一项横断面研究:有精神病的年轻人对以大麻为重点的减少伤害干预的偏好:一项横断面研究。
Can J Psychiatry. 2024 Jul;69(7):524-535. doi: 10.1177/07067437241242395. Epub 2024 Apr 4.

引用本文的文献

1
Factors Influencing Co-Use of Tobacco and Cannabis Amongst Young Adults in UK Further Education Colleges: A Qualitative Study.英国继续教育学院中影响年轻人烟草与大麻共同使用的因素:一项定性研究
Drug Alcohol Rev. 2025 Sep;44(6):1648-1657. doi: 10.1111/dar.70002. Epub 2025 Jun 24.
2
Drug-Use Safety Enhancement Model-Theory and Application.药物使用安全增强模型——理论与应用
Public Health Chall. 2024 Dec 21;3(4):e70016. doi: 10.1002/puh2.70016. eCollection 2024 Dec.
3
Commentary on Pessar et al.: 'Downscaling' United States state cannabis policy to investigate environmental and social impacts on cannabis use.关于佩萨尔等人的评论:将美国州级大麻政策“缩小规模”以调查对大麻使用的环境和社会影响。
Addiction. 2025 Jan;120(1):171-173. doi: 10.1111/add.16694. Epub 2024 Oct 14.

本文引用的文献

1
Association of Racial Disparity of Cannabis Possession Arrests Among Adults and Youths With Statewide Cannabis Decriminalization and Legalization.成年人和青少年因持有大麻被捕的种族差异与大麻在全州范围的非刑罪化和合法化有关。
JAMA Health Forum. 2021 Oct 29;2(10):e213435. doi: 10.1001/jamahealthforum.2021.3435. eCollection 2021 Oct.
2
Mechanisms of Behavior Change in Substance Use Disorder With and Without Formal Treatment.物质使用障碍中伴有和不伴有正式治疗的行为改变机制。
Annu Rev Clin Psychol. 2022 May 9;18:497-525. doi: 10.1146/annurev-clinpsy-072720-014802. Epub 2022 Feb 9.
3
Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints.描述治疗过程中大麻使用减少和功能变化的特征:新临床终点的初步步骤。
Psychol Addict Behav. 2022 Aug;36(5):515-525. doi: 10.1037/adb0000817. Epub 2022 Jan 27.
4
Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.评估大麻使用减少风险作为大麻使用障碍的替代临床结局。
Psychol Addict Behav. 2022 Aug;36(5):505-514. doi: 10.1037/adb0000760. Epub 2021 Jul 1.
5
Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State.在华盛顿州的初级保健患者的电子健康记录中记录的医用大麻使用和相关健康状况的流行率。
JAMA Netw Open. 2021 May 3;4(5):e219375. doi: 10.1001/jamanetworkopen.2021.9375.
6
Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.大麻使用、滥用和戒断:大麻素机制、临床和临床前研究结果。
J Neurochem. 2021 Jun;157(5):1674-1696. doi: 10.1111/jnc.15369. Epub 2021 May 16.
7
Cannabis use and cannabis use disorder.大麻使用和大麻使用障碍。
Nat Rev Dis Primers. 2021 Feb 25;7(1):16. doi: 10.1038/s41572-021-00247-4.
8
A qualitative review of cannabis stigmas at the twilight of prohibition.对大麻污名在禁令末期的定性综述。
J Cannabis Res. 2020 Dec 7;2(1):46. doi: 10.1186/s42238-020-00056-8.
9
Emerging Use of Epidiolex (Cannabidiol) in Epilepsy.大麻二酚(Epidiolex)在癫痫治疗中的新应用。
J Pediatr Pharmacol Ther. 2020;25(6):485-499. doi: 10.5863/1551-6776-25.6.485.
10
Treating cannabis use disorder: Exploring a treatment as needed model with 34-month follow-up.治疗大麻使用障碍:探索按需治疗模式并进行34个月随访。
J Subst Abuse Treat. 2020 Oct;117:108088. doi: 10.1016/j.jsat.2020.108088. Epub 2020 Jul 20.